Oral strontium chloride alleviates ovariectomy- induced bone loss in rats by remodeling the gut microbiota

Background Postmenopausal osteoporosis (PMOP) is a common skeletal disorder caused by estrogen loss, which shifts bone remodeling toward resorption. Sr is a bone-seeking trace element with established effects on bone turnover and microarchitecture, but its relationship with gut microbial and fecal metabolic changes in PMOP is not well defined. Objective We asked whether oral SrCl₂ reduces OVX-induced bone loss and whether any skeletal benefit coincides with gut microbiota and fecal metabolite changes. Methods Female Sprague–Dawley rats were sham-operated or ovariectomized (OVX). OVX animals received vehicle or SrCl₂·6H₂O (200 mg/kg/day) for 42 days (n = 6 per group). We measured serum turnover markers and cytokines, femoral biomechanics, trabecular microarchitecture and histomorphometry, and profiled the fecal microbiota (16S rRNA sequencing) and metabolome (untargeted LC-MS). MC3T3-E1 osteoblasts challenged with dexamethasone were used to test direct effects of Sr. Results OVX raised bone turnover and IL-6 and reduced biomechanical and trabecular parameters; Sr reversed these changes. Sr also shifted the microbiota (higher Romboutsia and Turicibacter, lower Streptococcus and Lachnospiraceae) and the fecal lipid profile, including the oxylipins (±)11(12)-EET, 9(S)-HOTrE and 13(S)-HOTrE and PC(18:2/20:3). Fecal (±)11(12)-EET correlated with bone turnover, microarchitecture and biomechanics. In DEX-treated MC3T3-E1 cells, Sr increased proliferation, osteogenic markers and mineralization. Conclusions Oral SrCl 2 protects against OVX-induced bone loss and promotes osteoblast differentiation and mineralization. The accompanying gut microbiota and fecal oxylipin changes suggest a microbiota–oxylipin–bone axis that warrants further testing; Sr-enriched foods may offer a route to support postmenopausal bone health.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-18
DOI
https://doi.org/10.21203/rs.3.rs-11604098/v1
Primary Topic
Bone health and osteoporosis research
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Oral strontium chloride alleviates ovariectomy- induced bone loss in rats by remodeling the gut microbiota

Xinke Li, Qianqian Yao, 学耀 西, 嘉祺 王 et al.
2 links
Research Square
Bone health and osteoporosis research
preprint

Oral strontium chloride alleviates ovariectomy- induced bone loss in rats by remodeling the gut microbiota

Xinke Li, Qianqian Yao, 学耀 西, 嘉祺 王, 南 郑, 亚南 高
preprint en

Abstract

Background Postmenopausal osteoporosis (PMOP) is a common skeletal disorder caused by estrogen loss, which shifts bone remodeling toward resorption. Sr is a bone-seeking trace element with established effects on bone turnover and microarchitecture, but its relationship with gut microbial and fecal metabolic changes in PMOP is not well defined. Objective We asked whether oral SrCl₂ reduces OVX-induced bone loss and whether any skeletal benefit coincides with gut microbiota and fecal metabolite changes. Methods Female Sprague–Dawley rats were sham-operated or ovariectomized (OVX). OVX animals received vehicle or SrCl₂·6H₂O (200 mg/kg/day) for 42 days (n = 6 per group). We measured serum turnover markers and cytokines, femoral biomechanics, trabecular microarchitecture and histomorphometry, and profiled the fecal microbiota (16S rRNA sequencing) and metabolome (untargeted LC-MS). MC3T3-E1 osteoblasts challenged with dexamethasone were used to test direct effects of Sr. Results OVX raised bone turnover and IL-6 and reduced biomechanical and trabecular parameters; Sr reversed these changes. Sr also shifted the microbiota (higher Romboutsia and Turicibacter, lower Streptococcus and Lachnospiraceae) and the fecal lipid profile, including the oxylipins (±)11(12)-EET, 9(S)-HOTrE and 13(S)-HOTrE and PC(18:2/20:3). Fecal (±)11(12)-EET correlated with bone turnover, microarchitecture and biomechanics. In DEX-treated MC3T3-E1 cells, Sr increased proliferation, osteogenic markers and mineralization. Conclusions Oral SrCl 2 protects against OVX-induced bone loss and promotes osteoblast differentiation and mineralization. The accompanying gut microbiota and fecal oxylipin changes suggest a microbiota–oxylipin–bone axis that warrants further testing; Sr-enriched foods may offer a route to support postmenopausal bone health.

Research Square
Chinese Academy of Agricultural Sciences (CN)
Agricultural Science and Technology Innovation Program
Good health and well-being
Bone health and osteoporosis research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon